Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 731-740 of 2858 for cancer

Edit search filters
  1. A Study of STRO-001 in Patients with Advanced B-Cell Malignancies

    Jacksonville, FL

  2. Study Of NanoKnife For Ablation Of Prostate Cancer In Low And Intermediate Risk Patients

    Rochester, MN

  3. A Study Of Apalutamide In Participants With High‑Risk, Localized Or Locally Advanced Prostate Cancer Who Are Candidates For Radical Prostatectomy

    Jacksonville, FL

  4. AB-2100, An Integrated Circuit T (ICT) Cell Therapy In Patients With Recurrent Clear-cell Renal Cell Carcinoma (CcRCC)

    Scottsdale/Phoenix, AZ

  5. International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)

    Rochester, MN

  6. A Study Of The Safety, Effectiveness And Maximum Tolerated Dose Of Oral PQR309 For Patients With Advanced Solid Tumors

    Rochester, MN

  7. Melanoma Relatlimab Nivolumab

    Jacksonville, FL, Rochester, MN

  8. Study Of Vorasidenib And Pembrolizumab Combination In Recurrent Or Progressive IDH-1 Mutant Glioma

    Jacksonville, FL

  9. A Study Of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab For Resected High-Risk Melanoma In Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study To Evaluate The Safety And Effectiveness Of Pembrolizumab Compared To Placebo In Resected High-risk Stage II Melanoma Patients

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer